Abstract: A refrigeration appliance device, in particular a household refrigeration appliance device, which achieves a high level of efficiency, includes an inner compartment, which forms a storage space for articles and which is made up at least of a first inner-compartment part and at least of a second inner-compartment part, which is adjacent to the first inner-compartment part and is formed separately from the first inner-compartment part. At least one prefabricated, in particular at least substantially panel-shaped, thermal insulation element, is fastened on at least one side of the inner compartment directed away from the storage space. A refrigeration appliance and/or freezer having the refrigeration appliance device, a modular system for manufacturing the refrigeration appliance device, and a method for producing the refrigeration appliance device, are also provided.

Abstract: An injection-molding method for selectively manufacturing molded parts with and without a breakthrough is disclosed. A molded part with a breakthrough is manufactured by positioning a mold core in a mold cavity, whereas a molded part without breakthrough is manufactured by removing the mold core at least partly from the mold cavity. The mold cavity delimited by a nozzle-side mold platen and an ejector-side mold platen. The mold core is movable relative to at least one of the mold platens, in particularly the nozzle-side mold platen, in an advance direction, where the mold core is closer to the nozzle-side mold platen and an opposite withdrawal direction. At least one protective measure is provided for protecting the inner surface facing the mold cavity of the respective mold platen, in particularly the nozzle-side mold platen, from adverse mechanical effects during movement of the mold core in the advance direction.

Abstract: An injection-moulding method for selectively manufacturing moulded parts with and without a breakthrough is disclosed. A moulded part with a breakthrough is manufactured by positioning a mould core in a mould cavity, whereas a moulded part without breakthrough is manufactured by removing the mould core at least partly from the mould cavity. The mould cavity delimited by a nozzle-side mould platen and an ejector-side mould platen. The mould core is movable relative to at least one of the mould platens, in particularly the nozzle-side mould platen, in an advance direction, where the mould core is closer to the nozzle-side mould platen and an opposite withdrawal direction. At least one protective measure is provided for protecting the inner surface facing the mould cavity of the respective mould platen, in particularly the nozzle-side mould platen, from adverse mechanical effects during movement of the mould core in the advance direction.

Abstract: Desmethylbalhimycin, a compound of the formula C.sub.65 H.sub.71 Cl.sub.2 N.sub.9 O.sub.24, desmethylleucylbalhimycin, a compound of the formula C.sub.59 H.sub.60 Cl.sub.2 N.sub.8 O.sub.23, desglucobalhimycin, a compound of the formula C.sub.60 H.sub.63 Cl.sub.2 N.sub.9 O.sub.19, ureidobalhimycin, a compound of the formula C.sub.67 H.sub.74 Cl.sub.2 N.sub.10 O.sub.25, desmethyl-desglucobalhimycin, a compound of the formula C.sub.59 H.sub.61 Cl.sub.2 N.sub.9 O.sub.19 and balhimycin V, a compound of the formula C.sub.73 H.sub.84 Cl.sub.2 N.sub.10 I.sub.26, methylbalhimycin, a compound of the formula C.sub.67 H.sub.75 Cl.sub.2 N.sub.9 O.sub.24 and balhimycin R, a compound of the formula C.sub.72 H.sub.83 Cl.sub.2 N.sub.9 O.sub.28, have an antibiotic action.

Abstract: Novel glycopeptides, a process for their preparation and their useDesmethylbalhimycin, a compound of the formula C.sub.65 H.sub.71 Cl.sub.2 N.sub.9 O.sub.24, desmethylleucylbalhimycin, a compound of the formula C.sub.59 H.sub.60 Cl.sub.2 N.sub.8 O.sub.23, desglucobalhimycin, a compound of the formula C.sub.60 H.sub.63 Cl.sub.2 N.sub.9 O.sub.19, ureidobalhimycin, a compound of the formula C.sub.67 H.sub.74 Cl.sub.2 N.sub.10 O.sub.25, desmethyl-desglucobalhimycin, a compound of the formula C.sub.59 H.sub.61 Cl.sub.2 N.sub.9 O.sub.19 and balhimycin V, a compound of the formula C.sub.73 H.sub.84 Cl.sub.2 N.sub.10 I.sub.26, methylbalhimycin, a compound of the formula C.sub.67 H.sub.75 Cl.sub.2 N.sub.9 O.sub.24 and balhimycin R, a compound of the formula C.sub.72 H.sub.83 Cl.sub.2 N.sub.9 O.sub.28, have an antibiotic action.

Abstract: Compounds 31668P and 31668U, a process for their production and their use.Compound 31668P and compound 31668U with the formulae ##STR1## have an antibiotic and an antitumor action.

Abstract: Oxirane-pseudooligosaccharides of the formula I ##STR1## in which z is zero or 1, their physiologically acceptable salts with acids, a process for their preparation, pharmaceutical preparations, and their use are described. The compounds have an .alpha.-glucosidase-inhibiting action.